This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Clostridium perfringens

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Clostridium perfringens is one species of the genus Clostridia. Classically, it is the prime organism that produces Clostridial myonecrosis - gas gangrene. However, it may also produce food poisoning.

Morphologically, it is a Gram-positive rod. It forms spores which are oval. Frequently, spores are sited in the sub-terminal or central part of the bacillus. C. perfringens is a non-motile organism.

C. perfringens grows in strictly anaerobic conditions. It produces haemolysis of blood agar at 37 degrees centigrade. Colonies are round with smooth edges.

It has a variety of pathogenic factors:

  • alpha-toxin:
    • one of five lecithinases produced
    • lyses membrane phospholipids to release phosphoryl choline, so causing cell lysis
    • the basis of the Nagler test
  • collagenase
  • hyaluronidase
  • a variety of haemolysins

Generally, it is sensitive to penicillin and metronidazole.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.